Apple Peptide Complex for Post-Surgical and Aesthetic Skin Recovery

Evaluation of the Efficacy of the Breast and Body Apple Peptide Complex in Post-Surgical Recovery and Non-Invasive Aesthetic Treatments in Medical Aesthetic Clinics, Dermatology Practices, and Med Spas

This clinical study evaluates a topical botanical formulation for supporting skin recovery following invasive and non-invasive aesthetic procedures. These procedures include liposuction, breast augmentation, Brazilian butt lift (BBL), laser treatments, and micro needling, pregnancy stretch mark and weight loss skin.

The study will assess the effects of the formulation on skin elasticity, hydration, and overall appearance when used as part of post-procedure care under the supervision of licensed medical professionals. Participants will apply the product to treatment areas over a defined study period, and outcomes will be compared to a control group receiving standard care or placebo.

The investigational product is a topical botanical formulation composed of plant-derived extracts including Pyrus malus (apple) fruit extract, Vanilla planifolia fruit extract, Jasminum officinale (jasmine) flower extract, and Vitis vinifera derivatives. These components are commonly used in dermatologic and cosmetic applications for their antioxidant, emollient, and skin barrier-supporting properties.

The formulation contains fatty acid components, including linoleic acid, which may contribute to maintaining skin hydration and barrier integrity. The product is intended for topical use following invasive and non-invasive aesthetic procedures, including liposuction, breast augmentation, Brazilian butt lift (BBL), laser therapies, and micro needling, pregnancy stretch mark and weight loss skin.

This study is designed as a randomized, interventional clinical trial conducted in medical aesthetic clinics, dermatology practices, and med spa settings. Participants were assigned to either an intervention group receiving the investigational product for standard post-procedure usage for topical skincare use.

Primary outcome measures include assessment of skin elasticity, hydration, and visible skin appearance. Secondary outcomes include time to visible recovery and incidence of adverse skin reactions.

Inclusion Criteria:

• Female participants aged 45-65 years
• Undergoing or have undergone aesthetic or surgical procedures (e.g., liposuction, breast augmentation, laser treatments, microneedling)
• Presence of skin concerns such as hyperpigmentation, scarring, or reduced elasticity
• Willing and able to comply with study procedures and follow-up
• Physician clearance for participation

Exclusion Criteria:

• Active skin infections, open wounds, or delayed wound healing
• Pregnancy or breastfeeding
• Use of conflicting topical or systemic treatments
• Known allergy to botanical ingredients in the formulation